Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Meta and Apple team up to make Muse AI models run better on Macs

October 15, 2026

Calgary Stampeders need help to reach CFL playoffs

October 15, 2026

Flintstones vitamins, Aleve and Claritin tablets hit in new recall

October 15, 2026

Sony made a $5,900 gold-plated Walkman MP3 player

October 15, 2026

Fisheries sector fund gets $300 million extension from Ottawa, Atlantic provinces

October 15, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Large Volume Parenteral (LVP) Market Poised for Growth Amid Rising Chronic Disease Prevalence
Press Release

Large Volume Parenteral (LVP) Market Poised for Growth Amid Rising Chronic Disease Prevalence

By News RoomJanuary 25, 20243 Mins Read
Large Volume Parenteral (LVP) Market Poised for Growth Amid Rising Chronic Disease Prevalence
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) — The “Large Volume Parenteral (LVP) Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering.

The global Large Volume Parenteral (LVP) market is anticipated to experience notable growth, registering a compound annual growth rate (CAGR) of 8.4% from 2023 to 2027. Newly consolidated data indicates an expansion of the market’s value, with projections reaching $15.78 billion by 2027. This phenomenal growth trajectory emerges against a backdrop of increasing chronic illness prevalence and rising healthcare demands worldwide.

The market’s progress is strengthened by significant product innovations introduced by key industry players seeking to reinforce their market presence. Notably, developments in efficient and safe delivery systems continue to revolutionize the LVP landscape, underscored by the launch of innovative glass vials that facilitate aseptic filling and finishing processes in parenteral formulations.

Recent strategic acquisitions, notably in the infusion systems domain, exemplify industry leaders’ intent to broaden their offerings and sharpen competitive edges, particularly within burgeoning markets like the United States.

A geographical analysis reveals that North America currently leads the LVP market share, with Asia-Pacific predicted to be the most rapidly growing region through the forecast period. The extensive study covers a gamut of regions, including Western Europe, Eastern Europe, South America, the Middle East, and Africa.

Strengthened by the escalation of chronic conditions which necessitate parenteral administration of medications and nutritional support, the market is set to witness a surge in demand. This is especially evident given projections for a near-doubling in the population segment suffering from chronic ailments in the United States by 2050.

The comprehensive report on the LVP market outlines the sales dynamics of sterile intravenous solutions and associated products, accounting for factory gate values from manufacturers and creators. Major players in the arena include global healthcare giants and specialized pharmaceutical firms, all contributing towards a robust competitive landscape.

The LVP market is delineated by a complex interplay of factors, including patient healthcare requirements, technological advancements, strategic industry movements, and an ever-evolving regulatory environment. It is these elements that will continue to sculpt the market’s contours as the healthcare industry pushes towards a more efficient and patient-centric future.

Key Points:

  • Global Large Volume Parenteral (LVP) market forecasted to reach $15.78 billion by 2027 with a CAGR of 8.4%.
  • Innovation and product development are pivotal trends stimulating market growth.
  • North America dominates the LVP market, while Asia-Pacific is the fastest-growing region.
  • The market is catalyzed by the increasing demand from chronic disease prevalence.
  • Market landscape features prominent healthcare and pharmaceutical companies committed to advancing the LVP domain.

A selection of companies mentioned in this report includes

  • Pfizer Inc.
  • Fresenius Kabi AG
  • Abbott Laboratories Inc.
  • Becton Dickinson and Company
  • Otsuka Holdings Co Ltd.
  • Baxter International Inc.
  • B Braun Melsungen AG
  • Grifols SA
  • Cipla Limited
  • ICU Medical Inc.
  • Biocon Limited
  • Sichuan Kelun Pharmaceutical Co. Ltd.
  • Alembic Pharmaceuticals Limited
  • Cadila Healthcare Ltd.
  • Gland Pharma Limited
  • Akums Drugs & Pharmaceuticals Ltd.
  • Beximco Pharmaceutical Ltd.
  • Nelson Laboratories LLC
  • Taj Pharmaceuticals Limited
  • Albert David Ltd.
  • Amanta Healthcare Ltd.
  • Unique Pharmaceutical Laboratories Ltd.
  • Ahlcon Parenterals India Ltd
  • Parenteral Drugs Limited
  • Abaris Healthcare Pvt. Ltd.
  • BML Parenteral Drugs
  • Denis Chem Lab Ltd
  • Pentagon Labs Ltd.
  • DJ Labs Pvt Ltd.
  • Higgs Healthcare.

For more information about this report visit https://www.researchandmarkets.com/r/nyievk

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Large Volume Parenteral (LVP) Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

vineyard vines Returns as Official Style of the Head Of The Charles® Regatta

Bigger & Better Than Ever: Laxmi & Chef Kunal Kapur Return With ‘Diwali Delights’ Season 2

2026 Chery International User Summit to Kick Off: LUXEED Set for Global Brand Launch

Going Asset Management Wins Capital’s Excellence Fund Award, Harnessing Technology to Enhance the Long-Term Value of Assets

Alation Honors 2026 AI Radicals Award Winners at revAlation

Supported Employment: Helping Individuals Build Meaningful Careers

“The Carbon Pursuit of Happiness” Premieres October 10: A New Chapter for In-Depth Dialogue on Health and Humanity

Evolution Metals & Technologies Corp. Raises Fiscal 2026 Revenue Guidance 62% at Midpoint to 11 Million and Reaffirms 460 Million Fiscal 2027 Outlook

Ufunded Launches “Spotlight” Series, Documenting the Minds Shaping Modern Trading

Editors Picks

Calgary Stampeders need help to reach CFL playoffs

October 15, 2026

Flintstones vitamins, Aleve and Claritin tablets hit in new recall

October 15, 2026

Sony made a $5,900 gold-plated Walkman MP3 player

October 15, 2026

Fisheries sector fund gets $300 million extension from Ottawa, Atlantic provinces

October 15, 2026

Latest News

Friends don’t let friends feed their data to AI agents

October 15, 2026

As bond yields rise, how to pick between a variable or fixed rate mortgage?

October 15, 2026

Carney says he expects nations, including U.S., to stay out of Alberta vote

October 15, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version